Lincare rises, falls
CLEARWATER, Fla.--Analysts don’t expect a private equity firm to follow in the Blackstone Group’s footsteps and buy Apria Healthcare competitor Lincare. Lincare’s stock was up 7.4% on June 19, the day news broke of Blackstone’s acquisition of Apria, but it was down 4.7% the next day. At press time in early July, Lincare’s stock was trading at $27.77 per share. Lincare’s size and current stock price make a buyout unlikely, even though it has better profit margins and cash flow than Apria, analysts told CNN.